1.
World Health Organization, Global progress report on HIV, viral hepatitis and sexually transmitted
infections, 2021. Accountability for the global health sector strategies 2016–2021: actions for impact.
(Online) Available from: https://www.who.int/publications/i/item/9789240027077 (Access date: 2022
January 28).
2.
de Sanjose S, Diaz M, Castellsague X, et al. Worldwide prevalence and genotype distribution of
cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis
7:453-459, 2007.
11
Yara BULE et al
3.
Looker KJ, Johnston C, Welton NJ, et al. The global and regional burden of genital ulcer disease
due to herpes simplex virus: a natural history modelling study. BMJ Glob Health 5:e001875, 2020.
4.
Kawado M, Hashimoto S, Ohta A, et al. Estimating nationwide cases of sexually transmitted
diseases in 2015 from sentinel surveillance data in Japan. BMC Infect Dis 20:77, 2020.
5.
Kim, S., Syphilis patients surging in Japan in 2022. The Mainichi. (Online) Available from: https://
mainichi.jp/english/articles/20220422/p2a/00m/0li/010000c (Access date: 2022 May 1)
6.
Konno R, Albero G and Bruni L, Japan Human Papillomavirus and Related Cancers, Fact Sheet
2019, No. 90. (Online) Available from: https://www.hpvworld.com/media/29/media_section/4/2/1642/
hpvworld-090.pdf (Access date: 2020 January 22).
7.
World Health Organization. Global health sector strategies on, respectively, HIV, viral hepatitis
and sexually transmitted infections for the period 2022-2030. (Online) Available from: https://
www.who.int/publications/i/item/9789240053779 (Access date: 2022 August 15)
8.
Ishiwata C. Sexual Health Education for School Children in Japan: The timing and contents. Japan
Medical Association Journal 54:155-160, 2011.
9.
Yeh PT, Kennedy CE, de Vuyst H, et al., Self-sampling for human papillomavirus (HPV) testing: a
systematic review and meta-analysis. BMJ Glob Health 4:e001351, 2019.
10.
World Health Organization. WHO guideline on self-care interventions for health and well-being,
2022 revision. (Online) Available from: https://www.who.int/publications/i/item/9789240052192 (Access
date: 2022 August 26).
11.
Serrano B, Ibanez R, Robles C, et al. Worldwide use of HPV self-sampling for cervical cancer
screening. Prev Med 154:106900, 2022.
12.
Gaydos CA, Crotchfelt KA, Shah N, et al. Evaluation of dry and wet transported intravaginal
swabs in detection of Chlamydia trachomatis and Neisseria gonorrhoeae infections in female soldiers by
PCR. J Clin Microbiol 40:758-761, 2002.
13.
Gaydos CA, Farshy C, Barnes M, et al. Can mailed swab samples be dry-shipped for the detection
of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis by nucleic acid
amplification tests? Diagn Microbiol Infect Dis 73:16-20, 2012.
14.
Lin CQ, Zeng X, Cui JF, et al. Stability Study of Cervical Specimens Collected by Swab and
Stored Dry Followed by Human Papillomavirus DNA Detection Using the cobas 4800 Test. J Clin
Microbiol 55:568-573, 2017.
15.
Jaya ZN, Mapanga W, van Niekerk B, et al. Mapping Evidence of Self-Sampling to Diagnose
Sexually Transmitted Infections in Women: A Scoping Review. Diagnostics (Basel) 12:1803, 2022.
16.
Lunny C, Taylor D, Hoang L, et al. Self-Collected versus Clinician-Collected Sampling for
Chlamydia and Gonorrhea Screening: A Systemic Review and Meta-Analysis. PLoS One 10:e0132776,
2015.
17.
Gupta S, Palmer C, Bik EM, et al. Self-Sampling for Human Papillomavirus Testing: Increased
Cervical Cancer Screening Participation and Incorporation in International Screening Programs. Front
Public Health 6:77, 2018.
12
Bulletin of Health Sciences Kobe
Viability and Acceptability of self-sampling in Kobe University
18.
Nakamura M, Nakade K, Orisaka S, et al. Comparison Study of BD Onclarity HPV With digene
HC2 High-Risk HPV DNA Test and Roche Cobas 4800 HPV for Detecting High-Risk Human
Papillomavirus in Japan. Am J Clin Pathol 151:263-269, 2019.
19.
Coorevits L, Vanscheeuwijck C, Traen A, et al. Evaluation of Copan FLOQSwab for the molecular
detection of Chlamydia trachomatis by Abbott RealTime CT PCR. Acta Clin Belg 70:398-402, 2015.
20.
Bule YP, Silva J, Carrilho C, et al. Human papillomavirus prevalence and distribution in self-
collected samples from female university students in Maputo. Int J Gynaecol Obstet 149:237-246, 2020.
21.
Resnick RM, Cornelissen MT, Wright DK, et al. Detection and typing of human papillomavirus in
archival cervical cancer specimens by DNA amplification with consensus primers. J Natl Cancer Inst
82:1477-1484, 1990.
22.
Gravitt PE, Peyton CL, Alessi TQ, et al. Improved amplification of genital human
papillomaviruses. J Clin Microbiol 38:357-361, 2000.
23.
Coutlee F, Gravitt P, Kornegay J, et al. Use of PGMY primers in L1 consensus PCR improves
detection of human papillomavirus DNA in genital samples. J Clin Microbiol 40:902-907, 2002.
24.
Kimura H, Shibata M, Kuzushima K, et al. Detection and direct typing of herpes simplex virus by
polymerase chain reaction. Med Microbiol Immunol 179:177-184, 1990.
25.
Ho, BS, Feng WG, Wong BK, et al. Polymerase chain reaction for the detection of Neisseria
gonorrhoeae in clinical samples. J Clin Pathol 45:439-442, 1992.
26.
Loeffelholz MJ, Lewinski CA, Silver SR, et al. Detection of Chlamydia trachomatis in
endocervical specimens by polymerase chain reaction. J Clin Microbiol 30:2847-2851, 1992.
27.
Palmer HM, Higgins SP, Herring AJ, et al. Use of PCR in the diagnosis of early syphilis in the
United Kingdom. Sex Transm Infect 79:479-483, 2003.
28.
Kengne P, Veas F, Vidal N, et al. Trichomonas vaginalis: repeated DNA target for highly sensitive
and specific polymerase chain reaction diagnosis. Cell Mol Biol (Noisy-le-grand) 40:819-931, 1994.
29.
Hamashima C, Sasaki S, Hosono S, et al. National Data Analysis and Systematic Review for
Human Resources for Cervical Cancer Screening in Japan. Asian Pac J Cancer Prev 22:1695-1702, 2021.
30.
Kudo R, Sekine M, Yamaguchi M, et al. Internet Survey of Awareness and Behavior Related to
HPV Vaccination in Japan. Vaccines (Basel) 9:87 2021.
31.
Palmer M, Katanoda K, Saito E, et al. National genotype prevalence and age distribution of human
papillomavirus from infection to cervical cancer in Japanese women: a systematic review and metaanalysis protocol. Syst Rev 10:135, 2021.
32.
Ban N and Fetters MD. Education for health professionals in Japan—time to change. The Lancet
378:1206-1207, 2011.
33.
Ghotbi N and Anai A. Assessment of the knowledge and attitude of female students towards
cervical cancer prevention at an international university in Japan. Asian Pac J Cancer Prev 13:897-900,
2012.
34.
Kawata K and Koga H. Sexually transmitted infections and cervical cancer: Knowledge and
prevention awareness among female university students in Japan. Nurs Open 7:1139-1145, 2020.
13
Yara BULE et al
35.
Kaneko N. Association between condom use and perceived barriers to and self-efficacy of safe sex
among young women in Japan. Nurs Health Sci 9:284-289, 2007.
36.
Paudyal P, Llewellyn C, Lau J, et al. Obtaining self-samples to diagnose curable sexually
transmitted infections: a systematic review of patients' experiences. PLoS One 10:e0124310, 2015.
37.
Fokom Domgue J, Futuh B, Ngalla C, et al. Feasibility of a community-based cervical cancer
screening with "test and treat" strategy using self-sample for an HPV test: Experience from rural
Cameroon, Africa. Int J Cancer 147:128-138, 2020.
38.
Wong EL, Cheung AW, Wong AY, et al. Acceptability and Feasibility of HPV Self-Sampling as an
Alternative Primary Cervical Cancer Screening in Under-Screened Population Groups: A Cross-Sectional
Study. Int J Environ Res Public Health 17:6245 2020.
39.
Silva J, Ribeiro J, Sousa H, et al. Oncogenic HPV Types Infection in Adolescents and University
Women from North Portugal: From Self-Sampling to Cancer Prevention. J Oncol 2011:953469, 2011.
40.
Kunitoki K, Funato M, Mitsunami M, et al. Access to HPV vaccination in Japan: Increasing social
trust to regain vaccine confidence. Vaccine 39:6104-6110, 2021.
41.
Ghaznavi C, Tanoue Y, Kawashima T, et al. Recent changes in the reporting of STIs in Japan
during the COVID-19 pandemic. Sex Transm Infect 0:1-4, 2022.
42.
Seike K, Maeda S, Kubota Y, et al. Prevalence and morbidity of urethral Trichomonas vaginalis in
Japanese men with or without urethritis. Sex Transm Infect 89:528-530, 2013.
43.
Grose RG, Chen JS, Roof KA, et al. Sexual and Reproductive Health Outcomes of Violence
Against Women and Girls in Lower-Income Countries: A Review of Reviews. J Sex Res 58:1-20, 2021.
14
Bulletin of Health Sciences Kobe
...